Enrica Perugini

TL;DR: In cardiac amyloidosis, CMR shows a characteristic pattern of global subendocardial late enhancement coupled with abnormal myocardial and blood-pool gadolinium kinetics and may prove to have value in diagnosis and treatment follow-up.

TL;DR: It is concluded that 99mTc-DPD scintigraphy is a useful step in the workup of the differential diagnosis of TTR versus AL etiology in patients with documented cardiac amyloidosis.

TL;DR: Adult patients with incidental or familial discovery of IVNC have an encouraging outlook, whereas those who have symptoms of heart failure, a history of sustained ventricular tachycardia or an enlarged left atrium have an unstable course and more severe prognosis.

TL;DR: Investigation in a large cohort of patients with hypertrophic cardiomyopathy followed up at a cardiology center serving both the pediatric and the adult population found young age at diagnosis, family history of HCM, and greater wall thickness are incremental risk factors for dilated-hypokinetic H CM, which carries an ominous prognosis.

TL;DR: Gd enhancement is common but not universally present in patients with cardiac amyloidosis, probably due to expansion of infiltrated interstitium and appears to be associated with impaired segmental and global contractility and a larger atrium.